Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BEVC is an early-stage venture capital firm located in Berkeley, California. Founded by a team of investors and scientists, the firm is dedicated to transforming cutting-edge science into disruptive companies. Established within a world-class innovation ecosystem, BEVC is closely connected to the Berkeley and UCSF research institutions, which enhances its investment capabilities.
The firm currently manages a portfolio of 8 companies, focusing on early-stage investments in the Pre-Seed, Seed, and Series A stages. BEVC's geographical focus is primarily on the San Francisco Bay Area, where it actively engages with the local startup community. The firm has built a reputation for its commitment to high-impact technologies, particularly in the sectors of healthcare, energy, and materials.
Notable milestones include the successful launch of several portfolio companies that have made significant advancements in their respective fields. BEVC's approach combines scientific rigor with entrepreneurial insight, positioning it as a key player in the early-stage investment landscape.
BEVC invests in transformational technology with high impact potential, specifically targeting the sectors of healthcare, energy, and materials. The firm focuses on early-stage investments, particularly in Pre-Seed, Seed, and Series A stages. Its investment strategy emphasizes the intersection of science, computation, and engineering, allowing it to identify and support groundbreaking innovations.
The firm seeks to partner with founders who are deeply knowledgeable in their fields and are working on technologies that can significantly alter existing paradigms. BEVC's geographical focus is on the San Francisco Bay Area, leveraging its connections within local research institutions to source high-quality deal flow. The firm is particularly interested in companies that demonstrate a clear path to market and possess a strong scientific foundation.
BEVC's portfolio consists of 8 notable companies, each contributing to advancements in their respective sectors:
These companies exemplify BEVC's commitment to investing in high-impact technologies that have the potential to transform their respective industries.
Rowan Chapman, Ph.D. - Co-Founder: Rowan has a background in biotechnology and has led multiple successful ventures in the life sciences sector.
Joshua James, Ph.D. - Investor: Joshua specializes in early-stage investments in healthcare and has a strong track record of identifying promising startups.
Widya Mulyasasmita, Ph.D. - Co-Founder: Widya brings expertise in materials science and has experience in commercializing advanced technologies.
Risa Stack, Ph.D. - Co-Founder: Risa has a background in biomedical engineering and focuses on health-related investments.
David Schaffer, Ph.D. - Founding Advisor: David is a prominent figure in the biotech field and provides strategic insights to the firm.
Marianne Wu, Ph.D. - Venture Partner: Marianne has extensive experience in venture capital and technology commercialization.
Jocelyne Cooke - CFO: Jocelyne oversees the financial operations of BEVC, ensuring sound fiscal management.
Advisors include notable figures such as Carolyn Bertozzi, Ph.D., Mike Biddle, Ph.D., Jennifer Chayes, Ph.D., Christina Curtis, Ph.D., MSc, Jennifer Doudna, Ph.D., Regis Kelly, Ph.D., OBE, Joshua Posamentier, Robert Tjian, Ph.D., and Greg Went, Ph.D., each contributing their expertise to support BEVC's mission.
Startups interested in pitching to BEVC should submit their proposals through the firm's website. The pitch deck should include a clear overview of the technology, market opportunity, and team qualifications. BEVC prefers concise presentations that highlight key metrics and milestones. Response times may vary, but founders can expect feedback within a few weeks of submission.
BEVC has been actively engaging with its portfolio and the broader innovation ecosystem, although no specific blog posts or recent updates have been detected. The firm continues to emphasize its commitment to investing in high-impact technologies and maintaining its presence in the Bay Area's vibrant startup landscape.
What are BEVC's investment criteria?
BEVC invests in early-stage companies primarily in the healthcare, energy, and materials sectors. The firm focuses on transformational technologies with high impact potential, particularly those that leverage scientific research.
How can startups apply or pitch to BEVC?
Startups interested in pitching to BEVC should prepare a detailed presentation that outlines their technology, market potential, and team expertise. Direct outreach through their website is encouraged.
What makes BEVC different from other venture capital firms?
BEVC distinguishes itself by its strong ties to leading research institutions like Berkeley and UCSF, which enhances its ability to identify and support groundbreaking innovations in science and technology.
What is BEVC's geographic scope?
The firm primarily focuses on investments within the San Francisco Bay Area, leveraging its local connections to foster collaboration and innovation.
What is BEVC's approach to post-investment involvement?
BEVC actively engages with its portfolio companies, providing operational support and strategic guidance to help them navigate the challenges of early-stage growth.
What is the typical check size for BEVC's investments?
BEVC typically invests in the Pre-Seed, Seed, and Series A stages, with check sizes varying based on the specific needs and potential of each startup.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.